NFIB and prostate carcinoma: Interestingly, in 5/9 genes (55.5%), i.e., ABHD2, DICER1, GSK3B, NR3C1, and NFIB mutations were localized to functional domains of their corresponding proteins, which suggest them to be highly critical genes for prostate cancers (Figure 4B).